Nine members of the HMO Research Network "will use detailed clinical profiles to search for potential subjects to enroll into … serious adverse events research projects using their electronic medical record databases," iSAEC said in a statement.
The consortium and the network will collaborate to identify genetic traits for adverse drug reactions.
The new partners include the University of Liverpool, Newcastle University, the HMO Research Network, and Cerner.
The SAEC will work with an HMO network to identify genetic variants for adverse reactions to antipsychotic medications.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.